Press Releases

Press Releases

  • October 19, 2018
    Aileron Announces Poster Presentations at Two Scientific Conferences in November
  • September 6, 2018
    Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer
  • August 7, 2018
    Aileron Therapeutics Reports Second Quarter 2018 Financial Results
  • August 2, 2018
    Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
  • July 31, 2018
    Aileron Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018
  • May 29, 2018
    Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
  • May 22, 2018
    Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
  • May 15, 2018
    Aileron Therapeutics Announces Changes to Management
  • May 9, 2018
    Aileron Therapeutics Reports First Quarter 2018 Financial Results
  • April 11, 2018
    Aileron Therapeutics Announces Publication by Researchers at Albert Einstein College of Medicine of ALRN-6924 Nonclinical Data in Acute Myeloid Leukemia